Serum 4-hydroxynonenal associates with the recurrence of patients with primary cerebral infarction.

Liu, Xingliang; Bai, Meiling; Fan, Lei; Lou, Zhan

Liu, Xingliang; Bai, Meiling; Fan, Lei; Lou, Zhan.

Afiliação

Liu X; Department of Neurology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Bai M; Hebei North University, Zhangjiakou, China.
Fan L; Department of Neurology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Lou Z; Department of Neurology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.

Front Cell Neurosci ; 16: 998512, 2022.

Article em En | MEDLINE | ID: mdl-36439197

Palavras-chave

4-hydroxynonenal; cerebral infarction; patients; recurrence; risk

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google